These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 1688646

  • 1. Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues.
    Meek TD, Lambert DM, Dreyer GB, Carr TJ, Tomaszek TA, Moore ML, Strickler JE, Debouck C, Hyland LJ, Matthews TJ.
    Nature; 1990 Jan 04; 343(6253):90-2. PubMed ID: 1688646
    [Abstract] [Full Text] [Related]

  • 2. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM, Bloom G, Rose SL, Pomeroy SM, O'Brien PO, Perez EE, Sleasman JW, Dunn BM.
    Virology; 2002 Jan 05; 292(1):137-49. PubMed ID: 11878916
    [Abstract] [Full Text] [Related]

  • 3. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
    Barrie KA, Perez EE, Lamers SL, Farmerie WG, Dunn BM, Sleasman JW, Goodenow MM.
    Virology; 1996 May 15; 219(2):407-16. PubMed ID: 8638406
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1.
    Paulus C, Ludwig C, Wagner R.
    Virology; 2004 Dec 05; 330(1):271-83. PubMed ID: 15527852
    [Abstract] [Full Text] [Related]

  • 11. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
    McQuade TJ, Tomasselli AG, Liu L, Karacostas V, Moss B, Sawyer TK, Heinrikson RL, Tarpley WG.
    Science; 1990 Jan 26; 247(4941):454-6. PubMed ID: 2405486
    [Abstract] [Full Text] [Related]

  • 12. The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles.
    Park J, Morrow CD.
    J Virol; 1992 Nov 26; 66(11):6304-13. PubMed ID: 1383561
    [Abstract] [Full Text] [Related]

  • 13. A human cell line constitutively expressing HIV-1 Gag and Gag-Pol gene products.
    Wang CT, Li JJ, Lai HY, Hu BS.
    J Med Virol; 1999 Jan 26; 57(1):17-24. PubMed ID: 9890417
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Morphogenic capabilities of human immunodeficiency virus type 1 gag and gag-pol proteins in insect cells.
    Hughes BP, Booth TF, Belyaev AS, McIlroy D, Jowett J, Roy P.
    Virology; 1993 Mar 26; 193(1):242-55. PubMed ID: 8438569
    [Abstract] [Full Text] [Related]

  • 16. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
    Dis Markers; 1990 Mar 26; 8(3):162-3. PubMed ID: 2125537
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M, Kulkosky J, Duan LX, Pomerantz RJ.
    J Hum Virol; 2000 Mar 26; 3(1):6-15. PubMed ID: 10774802
    [Abstract] [Full Text] [Related]

  • 18. Amino acid insertions near Gag cleavage sites restore the otherwise compromised replication of human immunodeficiency virus type 1 variants resistant to protease inhibitors.
    Tamiya S, Mardy S, Kavlick MF, Yoshimura K, Mistuya H.
    J Virol; 2004 Nov 26; 78(21):12030-40. PubMed ID: 15479842
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D, Bolesta E, Naito T, Gzyl J, Kaneko Y, Kozbor D.
    J Hum Virol; 2001 Nov 26; 4(6):306-16. PubMed ID: 12082397
    [Abstract] [Full Text] [Related]

  • 20. Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles.
    Mak J, Jiang M, Wainberg MA, Hammarskjöld ML, Rekosh D, Kleiman L.
    J Virol; 1994 Apr 26; 68(4):2065-72. PubMed ID: 7511167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.